Page last updated: 2024-11-04

temozolomide and Paraneoplastic Syndromes

temozolomide has been researched along with Paraneoplastic Syndromes in 3 studies

Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.

Research Excerpts

ExcerptRelevanceReference
"Necrolytic migratory erythema is an obligatory paraneoplastic syndrome."1.39Necrolytic migratory erythema in a patient with neuroendocrine carcinoma. ( Enk, AH; Gronau, M; Hassel, JC; Jäger, D, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koreen, L1
He, SX1
Johnson, MW1
Hackel, RE1
Khan, NW1
Heckenlively, JR1
Gronau, M1
Jäger, D1
Enk, AH1
Hassel, JC1
Carpentier, AF1

Reviews

1 review available for temozolomide and Paraneoplastic Syndromes

ArticleYear
Neuro-oncology: the growing role of chemotherapy in glioma.
    The Lancet. Neurology, 2005, Volume: 4, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemotherapy, Adjuvant; D

2005

Other Studies

2 other studies available for temozolomide and Paraneoplastic Syndromes

ArticleYear
Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:1

    Topics: Acute Disease; Antineoplastic Agents, Alkylating; Autoantibodies; Autoantigens; Blotting, Western; C

2011
Necrolytic migratory erythema in a patient with neuroendocrine carcinoma.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Capecitabine; Carcinoma, Neur

2013